Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications
- 1 January 1987
- Vol. 1 (4) , 347-388
- https://doi.org/10.1002/syn.890010408
Abstract
The present review focuses on the hypothesized D1/D2 dopamine (DA) receptor classification, originally based on the form of receptor coupling to adenylate cyclase activity. The pharmacological effects of compounds exhibiting putative selective agonist or antagonist profiles at those DA receptors positively coupled to adenylate cyclase activity (D1 DA receptors) are extensively reviewed. Comparisons are made with the effects of putative selective D2 DA receptor agonists and antagonists, and on the basis of this work, the DA receptor classification is critically evaluated. A variety of biochemical, behavioral, and electrophysiological evidence is presented which supports the view that D1 and D2 DA receptors can interact in both an opposing and synergistic fashion. Particular attention is focused on the possibility that D1 receptor stimulation is required to enable the expression of certain D2 receptor‐mediated effects, and the functional consequences of this form of interaction are considered. A hypothetical model is presented which considers how both the opposing and enabling forms of interaction between D1 and D2 DA receptos can control behavioral expression. Finally, the clinical relevance of this work is discussed and the potential use of selective D1 receptor agonists and antagonists in the treatment of psychotic states and Parkinson's disease is considered.Keywords
This publication has 343 references indexed in Scilit:
- In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Selective D-1 dopamine receptor agonist treatment of parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1987
- Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinitiesin vitroJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: Central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in ratsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineLife Sciences, 1983
- 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptorsLife Sciences, 1981
- Treatment of Parkinsonʼs disease with dopamine agonists: A reviewThe Lancet Healthy Longevity, 1979
- Effects of neuroleptics on 3H-haloperidol and 3H-CIS (Z)-flupenthixol binding and on adenylate cyclase activity in vitroLife Sciences, 1978